A cross-neutralizing antibody between HIV-1 and influenza virus.
Incessant antigenic evolution enables the persistence and spread of influenza virus in the human population. As the principal target of the immune response, the hemagglutinin (HA) surface antigen on influenza viruses continuously acquires and replaces N-linked glycosylation sites to shield immunogen...
Main Authors: | Chang-Chun D Lee, Yasunori Watanabe, Nicholas C Wu, Julianna Han, Sonu Kumar, Tossapol Pholcharee, Gemma E Seabright, Joel D Allen, Chih-Wei Lin, Ji-Rong Yang, Ming-Tsan Liu, Chung-Yi Wu, Andrew B Ward, Max Crispin, Ian A Wilson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-03-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1009407 |
Similar Items
-
In vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity
by: Nicholas C. Wu, et al.
Published: (2017-05-01) -
The interaction of influenza virus with neutralizing antibody
by: Taylor, Howard Paul
Published: (1986) -
Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin
by: Sabari Nath Neerukonda, et al.
Published: (2020-07-01) -
Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding
by: Lauren E. Gentles, et al.
Published: (2020-05-01) -
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
by: Yasunori Watanabe, et al.
Published: (2020-05-01)